Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913689 · ClinicalTrials.gov registry record
StimRouter Registry Clinical Protocol
A clinical trial of Chronic Pain and Peripheral Neuropathy, sponsored by Bioness.
- Completed
- Registry status
- 62
- Enrollment target
- 9
- Study locations
NCT03913689: Completed study of Chronic Pain and Peripheral Neuropathy, sponsored by Bioness.
NCT03913689 is a study of Chronic Pain and Peripheral Neuropathy that has completed, run by Bioness. The registered enrollment target is 62 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03913689, a study of Chronic Pain and Peripheral Neuropathy, has completed, sponsored by Bioness.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 9
- Study locations
Study Summary
This Registry study will prospectively evaluate the long-term effectiveness, safety, and tolerability of the StimRouter Neuromodulation System, along with evaluating the technical performance of StimRouter, surgical outcomes, health-related quality of life, concomitant medical use, and subject's impression of improvement.
Primary Outcome
Change from baseline to 6 months post-permanent implant in aversge pain assessed by using a Numeric Rating Scale
Conditions Studied
Interventions
- DEVICE StimRouter Neuromodulation System
Study Locations (9)
California
- University of California San Diego - La Jolla
- California Orthopedics & Spine - Larkspur
- Stanford University - Redwood City
Connecticut
- Stamford Hospital - Stamford
District of Columbia
- International Spine,Pain and Performance Center - Washington D.C.
Louisiana
- Warner Orthopedics - Baton Rouge
Pennsylvania
- Albert Einstein/Moss Rehab - Elkins Park
Virginia
- Valley Sports and Spine Clinic - Blacksburg
Wisconsin
- Advocate Aurora Health - Oshkosh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2024-06-30 |
What the finished NCT03913689 record still lists
NCT03913689 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower).
The record links to 7 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which StimRouter Neuromodulation System is the first listed.
NCT03913689 lists 9 locations in 7 states (California, Connecticut, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT03913689 about?
NCT03913689 is a clinical study titled "StimRouter Registry Clinical Protocol". This Registry study will prospectively evaluate the long-term effectiveness, safety, and tolerability of the StimRouter Neuromodulation System, along with evaluating the technical performance of StimRouter, surgical outcomes, health-related quality of life, concomitant medical use, and subject's imp...
What is the current status of trial NCT03913689?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2019-06-26. Estimated completion is 2024-06-30.
What conditions does trial NCT03913689 study?
This clinical trial studies the following conditions: Chronic Pain, Peripheral Neuropathy, Nervous System Diseases, Peripheral Nerve Injuries, Peripheral Nervous System Diseases.
What interventions are being tested in trial NCT03913689?
The interventions under investigation include: StimRouter Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT03913689?
This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03913689 being conducted?
This trial has 9 study locations across California, Connecticut, District of Columbia, Louisiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03913689's enrollment target sits among peer trials
62 175th of 301 higher than 127 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI